Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscularor neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease

Details for Australian Patent Application No. 2006204785 (hide)

Owner Regenerx Biopharmaceuticals, Inc.

Inventors Goldstein, Allan L.; Finkelstein, Jack Jr.

Agent Wrays

Pub. Number AU-B-2006204785

PCT Pub. Number WO2006/076588

Priority 60/643,307 13.01.05 US

Filing date 13 January 2006

Wipo publication date 20 July 2006

Acceptance publication date 25 November 2010

International Classifications

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/076588 Priority application(s): WO2006/076588

25 November 2010 Application Accepted

  Published as AU-B-2006204785

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204787-Perfusion and/or preservation solution for organs

2006204784-Peptides for delivery of mucosal vaccines